Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-alpha-4 integrin (Clone 21.6)
Applications | Bl, ELISA |
Reactivities | Human |
Recombinant Anti-tau (Clone Tau-5)
Applications | EM, IF |
Reactivities | Human, Mouse, Rat, Sheep |
Recombinant Anti-alpha-4 integrin (Clone 21.6)
Applications | Bl, ELISA |
Reactivities | Human |
Recombinant Anti-tau (Clone Tau-5)
Applications | EM, IF |
Reactivities | Human, Mouse, Rat, Sheep |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-TGFalpha (Clone tAb2)
Applications | Dot, ELISA |
Reactivities | Human |
Recombinant Anti-Basigin (Clone Ab-1)
Applications | Bl, ELISA |
Reactivities | Human |
Recombinant Anti-Interleukin 7 Receptor (Clone YIL7R323)
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-Interleukin 7 Receptor (Clone YIL7R323)
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-Integrin α-M (Clone 107)
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-LeY (Clone BR96)
Applications | ELISA, IHC |
Reactivities | Human |
Recombinant Anti-LeY (Clone BR96)
Applications | ELISA, IHC |
Reactivities | Human |